CIK 0001711279 · Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 821080209
- Phone
- (412) 586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,966,069
- in 2 filings, $18.0M under 10b5-1 plans
Net −$17,966,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-14 | Mazzacco Catherine Director | Grant or award · Stock Option (Right to Buy) | +1,187 | 1,187 | ||
| 2026-09-14 | Mazzacco Catherine Director | Grant or award · Restricted Stock Units | +471 | 471 | ||
| 2026-09-14 | Sutherland Everett Rand Director | Grant or award · Stock Option (Right to Buy) | +1,187 | 1,187 | ||
| 2026-09-14 | Sutherland Everett Rand Director | Grant or award · Restricted Stock Units | +471 | 471 | ||
| 2026-09-14 | Mason Christopher Director | Grant or award · Stock Option (Right to Buy) | +1,187 | 1,187 | ||
| 2026-09-14 | Mason Christopher Director | Grant or award · Restricted Stock Units | +471 | 471 | ||
| 2026-09-14 | JANNEY DANIEL Director | Grant or award · Stock Option (Right to Buy) | +1,187 | 1,187 | ||
| 2026-09-14 | JANNEY DANIEL Director | Grant or award · Restricted Stock Award | +471 | 471 | ||
| 2026-09-14 | Gangolli Julian S Director | Grant or award · Stock Option (Right to Buy) | +1,187 | 1,187 | ||
| 2026-09-14 | Gangolli Julian S Director | Grant or award · Restricted Stock Units | +471 | 471 | ||
| 2026-09-14 | ROSSI DINO A Director | Grant or award · Stock Option (Right to Buy) | +1,187 | 1,187 | ||
| 2026-09-14 | ROSSI DINO A Director | Grant or award · Restricted Stock Units | +471 | 471 | ||
| 2026-09-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −520 | $354.54 | $184K | 1,326,625 |
| 2026-09-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −2,006 | $355.57 | $713K | 1,324,619 |
| 2026-09-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −3,267 | $356.37 | $1.2M | 1,321,352 |
| 2026-09-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −3,962 | $357.57 | $1.4M | 1,317,390 |
| 2026-09-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −3,180 | $358.42 | $1.1M | 1,314,210 |
| 2026-09-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −3,392 | $359.39 | $1.2M | 1,310,818 |
| 2026-09-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −2,320 | $360.47 | $836K | 1,308,498 |
| 2026-09-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −1,242 | $361.61 | $449K | 1,307,256 |
Page 1 of 35 · 688 trades